Home › Hidradenitis Suppurativa › Texas
Hidradenitis Suppurativa clinical trials in Texas
8 studies for Hidradenitis Suppurativa are looking for participants at sites in Texas.
Cities in Texas
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Center for Clinical Studies-Lee, Webster
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Dallas
- Oruka Therapeutics Investigative Site, Missouri City
- Oruka Therapeutics Investigative Site, San Antonio
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Sep 24, 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US021, Bellaire
- Investigative Site US078, Dallas
- Investigative Site US010, Dallas
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Bellaire Dermatology Associates Bda, Bellaire
- Texas Dermatology Research Center, Dallas
- 3A Research Llc West Location, El Paso
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 6, 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 to 71 · All sexes · Updated Apr 16, 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Arlington Research Center, Inc., Arlington
- Texas Dermatology Research Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07244263From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.